An Early Phase 1 interventional study of Joint Effusion via 60 mL Sterile Saline and Intra-articular Lidocaine in Muscle Inhibition and Knee Injury Simulation, sponsored by University of Central Florida. Recruiting at 1 site in United States. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.
Sponsored by University of Central Florida · Early Phase 1, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 94 studies in Knee Injuries with a site in United States — 16 open to participants now, 24 under way, 1 of them phase 3. Knee Injuries · United States.
Among the 94 studies in Knee Injuries with a site in United States, this one is the 36th largest by planned enrollment of the 75 interventional ones that give a count, is one of 3 that started in 2026, is one of 2 in phase 1, reaches primary completion later than 14 of the 23 other live ones, and was the 90th registered.
267 studies on the registry are indexed under Knee Injuries; 59 are open to participants now.
Browse Knee Injuries studies →16 of the 94 studies in Knee Injuries with a site in United States are open now. Recruiting first, the newest first:
Smith & Nephew, Inc. · Sites in United States
Ages 18+
Stryker Endoscopy · Sites in United States
Ages 18+
University of North Carolina, Chapel Hill · Sites in United States
Ages 16–35
Connecticut Children's Medical Center · Sites in United States
Ages 12–18
Marquette University · Sites in United States
Ages 18–64 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 42 Knee Injuries studies recruiting now, 12 (29%) set no upper age limit and 27 (64%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 30 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
94 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 5 · Phase 3 10 · Phase 4 2
First in 2002; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 45 is close to the median of 49 across 178 interventional studies indexed under Knee Injuries.
Median enrollment 40 across the 75 interventional studies, 170 across the 19 observational. Of the 59 that completed or were terminated, 26 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 94 have an industry lead sponsor. The 10 most frequent:
University of Central Florida is the lead sponsor of 104 studies on the registry; 42 are open to participants now.
University of Central Florida has 2 studies filed under Knee Injuries — fewer than ten, so there is no comparison to draw.
12 of the studies in Knee Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05652270Dartmouth-Hitchcock Medical CenterMaximizing Patient Goal Attainment | 2026-11-30 |
| NCT05824676Hartford HospitalDePuy Synthes Variable Angle LCP Patella Plating System Study | 2026-12 |
| NCT04109638Stanford UniversityPulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery | 2027-02 |
| NCT06916728Smith & Nephew, Inc.A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Care (SSOC) Used for the Treatment of Joint Surface Lesions of the Knee | 2027-02-05 |
| NCT03543098University of PittsburghSTaR Trial: Multiple Ligament Knee Injuries | 2027-06 |
Add all 12 to your calendar (.ics) → With an account.
Among the 94 studies in Knee Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study investigates how simulated knee injury-via artificial joint effusion or deafferentation-affects quadriceps motor unit behavior in healthy young adults. Participants will complete neuromuscular testing during a single 2-hour lab session. This research seeks to improve understanding of muscle inhibition and inform interventions after real-world knee trauma.
Using a controlled laboratory model, the investigators will simulate knee injury through two methods: (1) intra-articular saline injection to induce effusion, and (2) intra-articular lidocaine injection to induce sensory deafferentation. Healthy participants aged 18-30 will undergo surface and decomposition EMG, isometric strength testing, and reflex measurements before and after the intervention. The primary outcome is motor unit recruitment characteristics, with secondary outcomes including quadriceps inhibition (Hoffmann reflex) and isometric peak torque. The findings will inform future neuromodulatory approaches in rehabilitation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
60 mL sterile saline injected into knee
Device: Joint Effusion via 60 mL Sterile Saline
Lidocaine (single intra-articular dose)
Drug: Intra-articular Lidocaine
Sham procedure with fake needle
Other: Sham injection
Injection of sterile saline into the knee joint to simulate joint swelling and induce quadriceps inhibition.
Injection of 7 mL lidocaine into the knee joint to simulate deafferentation by temporarily blocking sensory input.
Simulated knee injection using a stage needle without skin penetration, used to blind participants and serve as control.
Motor Unit Recruitment (amplitude relative to recruitment threshold)
Measured via surface EMG decomposition
Time frame: Baseline, 0, 30, and 60 minutes post-intervention
Motor Unit Recruitment (firing rate relative to recruitment threshold)
Measured via surface EMG decomposition
Time frame: Baseline, 0, 30, and 60 minutes post-intervention
Quadriceps Inhibition (Hoffmann Reflex)
Measured with femoral nerve stimulation
Time frame: Baseline, 0 and 60 minutes post-intervention
Isometric Peak Torque (Quadriceps Strength)
Measured with isokinetic dynamometer (Biodex)
Time frame: Baseline and 60 minutes post-intervention
Plan to share: Yes — De-identified individual participant data (IPD) related to primary and secondary outcomes, including motor unit recruitment characteristics, quadriceps strength, and Hoffmann reflex measurements, will be shared with qualified researchers upon reasonable request.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: The IPD and supporting documentation will be available beginning 6 months after publication of the primary manuscript. Data will remain available for 5 years following that date.
Access criteria: Qualified researchers with appropriate data use agreements in place may request access. Requests should be submitted to the Principal Investigator via email and will be reviewed by the study team. Data will be shared via secure file transfer protocols.
No publications or documents are linked to this record.
Start is estimated for Aug 2026; primary completion for Aug 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Central Florida →